Department of Cell and Cancer Biology

Department of Cell and Cancer Biology Postdoc Profiles

Postdoctoral fellows

 Photo of Dr. Himadri Biswas

Himadri Biswas, Ph.D.pm

Zou lab, BHS 440, (419) 383-4164
himadri.biswas@utoledo.edu

Education:
B.S., 2004 - Microbiology, University of Calcutta, Kolkata, West Bengal, India
M.S., 2006 - Biotechnology, University of Burdwan, Purba Bardhaman, West Bengal, India
Ph.D., 2016 - Biochemistry, Univ of Calcutta, Kolkata, West Bengal, India

Research Interests:  Eludicating the structure-function relationships of ATR (ataxia telangiectasia and Rad3-related) prolyl isomers on carcinogenesis and tumorigenesis
Photo of Dr. Megan Dreier

Megan Dreier, Ph.D.pm

de la Serna lab, BHS 303, (419) 383-4133
megan.dreier@utoledo.edu

Education
B.S., 05/2007 - Biology, University of Toledo, Toledo, Ohio
Ph.D., 05/2012 - Cell and Molecular Biology, University of Toledo

Research interests:  Cell cycle and tumor biology; currently studying the effects of the inhibition of chromatin regulators on melanocyte development in melanoma 

Photo of Dr. Shruti Ghai

Shruti Ghai, Ph.D.pm

Su lab, BHS 466, (419) 383-4159 
shrutirakesh.ghai@utoledo.edu

Education

B.Tech, 2016 - D.Y. Patil University, Navi Mumbai, India
M.S., 2017 - Georgetown University, Washington, DC, USA
Ph.D., 2024 - University of Toledo, Cell & Cancer Biology, Toledo, OH, USA

Photo of Dr. Guoyi Jiang

Guoyi Jiang, Ph.D.pm

S-H Liu lab, HEB 225, (419) 383-6489
guoyi.jiang@utoledo.edu

Education

Ph.D., 2024 - Pharmaceutics, University of Houston, College of Pharmacy, Houston, TX
M.Med., 2017 - Pharmaceutical Analysis, Nanjing Medical University, Nanjing, China
B.S., 2014 - Pharmacy, Nanjing Medical University, Nanjing, China

Research interests:   

I aim to innovate cancer therapy by harnessing exosomes as programmable drug delivery vehicles. My research integrates molecular engineering, tumor immunology, and bioanalytical science to overcome biological barriers in pancreatic cancer. I design targeting peptides to enhance specificity and minimize immune clearance. Through advanced models and pharmacokinetic tools, I translate bench discoveries toward personalized medicine. My goal is to bridge nanotechnology and oncology for smarter, safer therapeutics.
 Sophia Josephraj

Sophia Josephraj, Ph.D.pm

Zhang lab, BHS 435, (419) 383-4322 
sophia.josephraj@utoledo.edu

Education

B.S., 2010 - Biochemistry, Holy Cross College, Bharthidasan University, Tiruchirapalli, Tamil Nadu, India
M.Sc., 2012 - Biochemistry, Holy Cross College, Bharthidasan University
M.Phil., 2013 - Biochemistry, Bharthidasan University
Ph.D., 2019 - Biochemistry, Annamalai University, Annamalainagar, Chidambaram, Tamil Nadu, India

Research interests:  1) Kinase transcriptions factors in gene expression regulation, signal transduction, cell growth and differentiation; 2) Multiple mechanisms of drug resistance in fatty acid synthase

photo of Dr. Bharti Sethi

Bharti Sethi, Ph.D.                                                                                                 

pubmed

S-H Liu lab, HEB 225, (419) 383-6489
bharti.sethi@utoledo.edu

Education

Ph.D., 2023 - Pharmaceutical Sciences, University of Nebraska Medical Center, Omaha, NE
M.S., 2011 - Pharmaceutical Sciences, I.K. Gujral Punjab Technical University, India
B.S., 2009 - Pharmacy, Kurukshera University, Kurukshetra, India

Research interests:   

My research interests are centered around identifying the clinically relevant molecular mechanisms that impact the initiation and progress of pancreatic cancer. Specifically, I am dedicated to discovering innovative therapeutic targets and devising personalized therapy approaches.
I am passionate about translating basic research findings into clinical applications to improve outcomes for cancer patients.

 picture of Dr. Shobhit Srivastava

Shobhit Srivastava, Ph.D.                                                                                               

pubmed

Raman lab, BHS 405, (419) 383-4165
shobhit.srivastava@utoledo.edu

Education:
BPharm.,  2008 - Uttar Pradesh Technical University, Lucknow, India
MPharm., 2010 - Uttar Pradesh Technical University, Lucknow, India
Ph.D., 2017 - King George's Medical University, Lucknow, India

Research Interests:  Elucidation of mechanistic basis for drug-resistance mechanism in metastatic triple-negative breast cancer (mTNBC) with an emphasis on targeting translation of oncogenic mRNAs; pharmaceutical chemistry, drug design, evaluation of drug toxicity and metabolomics

Photo of Dr. Min Tang

Min Tang, M.D.                                                                                                            

Li lab, BHS 302, (419) 383-4446                                                                           Link to Dr. Tang's professional publications                  
min.tang@utoledo.edu

Education:
B.S., 2006 - Clinical Medicine, Luzhou Medical College, Sichuan, China
M.S., 2011 - Radiology, Chongqing Medical University, Chongqing, China
M.D., 2021 - Oncology, Chongqing Medical University, Chongqing, China

Research Interests: The impact of bone microenvionrment and therapies on prostate cancer metastasis, dissemination, and dormancy. 

Photo of Dr. Harshini Vemula

Harshini  Vemula,Ph.D.pm

Saladi lab, BHS 371, (419) 383-6572
harshini.vemula@utoledo.edu

Education:
B.V.Sc., A.H. 2014 - Sri Venkateswara Veterinary University, Tirupati, India
M.V.Sc., 2017 - Sri Venkateswara Veterinary University, Tirupati, India
Ph.D., 2021 - Tamil Nadu Veterinary and Animal Sciences University, Chennai, India

Research Interests:  Understanding mechanisms by which deregulated epigenetic factors (KDM4A and ACTL6A) promote oncogenic transcriptional program.

 Xunzhen Zheng

Xunzhen (Sean) Zheng, M.D.pm

JT Zhang lab, BHS 435, (419) 383-4322
xunzhen.zheng@utoledo.edu

Education:
M.S., M.D., 06/1997 - Hematology, Central South Univ, Xiangya Medical College, Changsha, Hunan, China

Research Interests:  The involvement of nitric oxide pathway in breast cancer development and treatment




Last Updated: 10/7/25